{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:07:46Z","timestamp":1788995266633,"version":"build-2803163510"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023MH067"],"award-info":[{"award-number":["ZR2023MH067"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"DOI":"10.1186\/s13019-026-04445-7","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:25:09Z","timestamp":1782217509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The critical role of the RUNX1\/NF-\u03baB transcriptional complex\u2013mediated PVAT\u2013VSMC axis in aortic dissection"],"prefix":"10.1186","volume":"21","author":[{"given":"Xin","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xizeng","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"8","key":"4445_CR1","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1161\/CIRCRESAHA.114.304936","volume":"116","author":"JD Humphrey","year":"2015","unstructured":"Humphrey JD, Schwartz MA, Tellides G, et al. Role of mechanotransduction in vascular biology: focus on thoracic aortic aneurysms and dissections[J\/OL]. Circul Res. 2015;116(8):1448\u201361. https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.304936.","journal-title":"Circul Res"},{"key":"4445_CR2","doi-asserted-by":"publisher","first-page":"1296778","DOI":"10.3389\/fendo.2023.1296778","volume":"14","author":"Y Tong","year":"2023","unstructured":"Tong Y, Zuo Z, Li X, et al. Protective role of perivascular adipose tissue in the cardiovascular system[J\/OL]. Front Endocrinol. 2023;14:1296778. https:\/\/doi.org\/10.3389\/fendo.2023.1296778.","journal-title":"Front Endocrinol"},{"key":"4445_CR3","doi-asserted-by":"publisher","first-page":"1151717","DOI":"10.3389\/fcvm.2023.1151717","volume":"10","author":"Y Adachi","year":"2023","unstructured":"Adachi Y, Ueda K, Takimoto E. Perivascular adipose tissue in vascular pathologies\u2014a novel therapeutic target for atherosclerotic disease?[J\/OL]. Front Cardiovasc Med. 2023;10:1151717. https:\/\/doi.org\/10.3389\/fcvm.2023.1151717.","journal-title":"Front Cardiovasc Med"},{"key":"4445_CR4","doi-asserted-by":"publisher","first-page":"1271051","DOI":"10.3389\/fimmu.2023.1271051","volume":"14","author":"M Cai","year":"2023","unstructured":"Cai M, Zhao D, Han X, et al. The role of perivascular adipose tissue-secreted adipocytokines in cardiovascular disease[J\/OL]. Front Immunol. 2023;14:1271051. https:\/\/doi.org\/10.3389\/fimmu.2023.1271051.","journal-title":"Front Immunol"},{"issue":"17","key":"4445_CR5","doi-asserted-by":"publisher","first-page":"8320","DOI":"10.3390\/ijms26178320","volume":"26","author":"R Niculescu","year":"2025","unstructured":"Niculescu R, Stoian A, Arb\u0103na\u0219i EM, et al. The dual role of perivascular adipose tissue in vascular homeostasis and atherogenesis: from physiology to pathological implications[J\/OL]. Int J Mol Sci. 2025;26(17):8320. https:\/\/doi.org\/10.3390\/ijms26178320.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4445_CR6","doi-asserted-by":"publisher","first-page":"44571","DOI":"10.1038\/srep44571","volume":"7","author":"SB Withers","year":"2017","unstructured":"Withers SB, Forman R, Meza-perez S, et al. Eosinophils are key regulators of perivascular adipose tissue and vascular functionality[J\/OL]. Sci Rep. 2017;7(1):44571. https:\/\/doi.org\/10.1038\/srep44571.","journal-title":"Sci Rep"},{"issue":"1","key":"4445_CR7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1186\/s12933-024-02549-9","volume":"23","author":"M Queiroz","year":"2024","unstructured":"Queiroz M, Sena CM. Perivascular adipose tissue: a central player in the triad of diabetes, obesity, and cardiovascular health[J\/OL]. Cardiovasc Diabetol. 2024;23(1):455. https:\/\/doi.org\/10.1186\/s12933-024-02549-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"16","key":"4445_CR8","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3390\/cells13161309","volume":"13","author":"S Sigdel","year":"2024","unstructured":"Sigdel S, Udoh G, Albalawy R, et al. Perivascular adipose tissue and perivascular adipose tissue-derived extracellular vesicles: new insights in vascular disease[J\/OL]. Cells. 2024;13(16):1309. https:\/\/doi.org\/10.3390\/cells13161309.","journal-title":"Cells"},{"key":"4445_CR9","doi-asserted-by":"publisher","first-page":"102683","DOI":"10.1016\/j.redox.2023.102683","volume":"62","author":"CK Cheng","year":"2023","unstructured":"Cheng CK, Ding H, Jiang M, et al. Perivascular adipose tissue: fine-tuner of vascular redox status and inflammation[J\/OL]. Redox Biol. 2023;62:102683. https:\/\/doi.org\/10.1016\/j.redox.2023.102683.","journal-title":"Redox Biol"},{"issue":"12","key":"4445_CR10","first-page":"2764","volume":"7","author":"SB Zhu","year":"2015","unstructured":"Zhu SB, Zhu J, Zhou ZZ, et al. TGF-\u03b21 induces human aortic vascular smooth muscle cell phenotype switch through PI3K\/AKT\/ID2 signaling[J]. Am J Translational Res. 2015;7(12):2764\u201374.","journal-title":"Am J Translational Res"},{"issue":"1","key":"4445_CR11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12964-022-00993-2","volume":"20","author":"G Cao","year":"2022","unstructured":"Cao G, Xuan X, Hu J, et al. How vascular smooth muscle cell phenotype switching contributes to vascular disease[J\/OL]. Cell Communication Signal. 2022;20(1):180. https:\/\/doi.org\/10.1186\/s12964-022-00993-2.","journal-title":"Cell Communication Signal"},{"issue":"1","key":"4445_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jjcc.2025.08.001","volume":"87","author":"K Ueda","year":"2026","unstructured":"Ueda K. Perivascular adipose tissue in cardiovascular disease: from mechanisms to therapeutic targets[J\/OL]. J Cardiol. 2026;87(1):64\u20138. https:\/\/doi.org\/10.1016\/j.jjcc.2025.08.001.","journal-title":"J Cardiol"},{"issue":"1","key":"4445_CR13","doi-asserted-by":"publisher","first-page":"9960","DOI":"10.1038\/s41598-024-60737-9","volume":"14","author":"A Wang","year":"2024","unstructured":"Wang A, Dong S, Liu B, et al. The role of RUNX1\/NF-\u03baB in regulating PVAT inflammation in aortic dissection[J\/OL]. Sci Rep. 2024;14(1):9960. https:\/\/doi.org\/10.1038\/s41598-024-60737-9.","journal-title":"Sci Rep"},{"issue":"1","key":"4445_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12933-025-02765-x","volume":"24","author":"Z Wang","year":"2025","unstructured":"Wang Z, Mu W, Xu R, et al. Perivascular adipose tissue dysfunction contributes to thoracic aortic aneurysm development[J\/OL]. Cardiovasc Diabetol. 2025;24(1):223. https:\/\/doi.org\/10.1186\/s12933-025-02765-x.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"4445_CR15","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.3390\/antiox12081595","volume":"12","author":"AW Man","year":"2023","unstructured":"Man AW, C, Zhou Y, Xia N, et al. Perivascular adipose tissue oxidative stress in obesity[J\/OL]. Antioxidants. 2023;12(8):1595. https:\/\/doi.org\/10.3390\/antiox12081595.","journal-title":"Antioxidants"},{"key":"4445_CR16","doi-asserted-by":"publisher","unstructured":"Hu H, Garcia-barrio M, Jiang Z et al. sheng,. Roles of perivascular adipose tissue in hypertension and atherosclerosis[J\/OL]. Antioxidants & Redox Signaling, 2021, 34(9): 736\u2013749. https:\/\/doi.org\/10.1089\/ars.2020.8103","DOI":"10.1089\/ars.2020.8103"},{"key":"4445_CR17","doi-asserted-by":"publisher","first-page":"1766197","DOI":"10.3389\/fphys.2026.1766197","volume":"17","author":"H Sowa","year":"2026","unstructured":"Sowa H, Karasaki K, Ishiwata M, et al. Perivascular adipose tissue and vascular inflammation: from biological insights to clinical implications[J\/OL]. Front Physiol. 2026;17:1766197. https:\/\/doi.org\/10.3389\/fphys.2026.1766197.","journal-title":"Front Physiol"},{"issue":"4","key":"4445_CR18","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.4110\/in.2018.18.e27","volume":"18","author":"JS Roh","year":"2018","unstructured":"Roh JS, Sohn DH. Damage-associated molecular patterns in inflammatory diseases[J\/OL]. Immune Netw. 2018;18(4):e27. https:\/\/doi.org\/10.4110\/in.2018.18.e27.","journal-title":"Immune Netw"},{"issue":"6","key":"4445_CR19","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1172\/JCI26498","volume":"116","author":"H Kanda","year":"2006","unstructured":"Kanda H. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity[J\/OL]. J Clin Invest. 2006;116(6):1494\u2013505. https:\/\/doi.org\/10.1172\/JCI26498.","journal-title":"J Clin Invest"},{"issue":"2","key":"4445_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1017\/S0007114508971282","volume":"100","author":"P Trayhurn","year":"2008","unstructured":"Trayhurn P, Wang B, Wood IS. Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity?[J\/OL]. Br J Nutr. 2008;100(2):227\u201335. https:\/\/doi.org\/10.1017\/S0007114508971282.","journal-title":"Br J Nutr"},{"issue":"10","key":"4445_CR21","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nri3520","volume":"13","author":"KJ Moore","year":"2013","unstructured":"Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: a dynamic balance[J\/OL]. Nat Rev Immunol. 2013;13(10):709\u201321. https:\/\/doi.org\/10.1038\/nri3520.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"4445_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri2921","volume":"11","author":"N Ouchi","year":"2011","unstructured":"Ouchi N, Parker JL, Lugus JJ, et al. Adipokines in inflammation and metabolic disease[J\/OL]. Nat Rev Immunol. 2011;11(2):85\u201397. https:\/\/doi.org\/10.1038\/nri2921.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"4445_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","volume":"9","author":"Z Deng","year":"2024","unstructured":"Deng Z, Fan T, Xiao C, et al. TGF-\u03b2 signaling in health, disease and therapeutics[J\/OL]. Signal Transduct Target Therapy. 2024;9(1):61. https:\/\/doi.org\/10.1038\/s41392-024-01764-w.","journal-title":"Signal Transduct Target Therapy"},{"issue":"8","key":"4445_CR24","doi-asserted-by":"publisher","first-page":"mjae039","DOI":"10.1093\/jmcb\/mjae039","volume":"16","author":"PM Huynh","year":"2025","unstructured":"Huynh PM, Wang F, An YA. Hypoxia signaling in the adipose tissue[J\/OL]. J Mol Cell Biol. 2025;16(8):mjae039. https:\/\/doi.org\/10.1093\/jmcb\/mjae039.","journal-title":"J Mol Cell Biol"},{"key":"4445_CR25","doi-asserted-by":"publisher","first-page":"1442086","DOI":"10.3389\/fphar.2024.1442086","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Chen Z, Xiao Y, et al. Cross-talks between perivascular adipose tissue and neighbors: multifaceted nature of nereids[J\/OL]. Front Pharmacol. 2024;15:1442086. https:\/\/doi.org\/10.3389\/fphar.2024.1442086.","journal-title":"Front Pharmacol"},{"issue":"1","key":"4445_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1042\/CS20190577","volume":"134","author":"S Ahmadieh","year":"2020","unstructured":"Ahmadieh S, Kim HW, Weintraub NL. Potential role of perivascular adipose tissue in modulating atherosclerosis[J\/OL]. Clin Sci. 2020;134(1):3\u201313. https:\/\/doi.org\/10.1042\/CS20190577.","journal-title":"Clin Sci"},{"key":"4445_CR27","doi-asserted-by":"publisher","first-page":"615503","DOI":"10.3389\/fphys.2020.615503","volume":"11","author":"Y Liu","year":"2020","unstructured":"Liu Y, Sun Y, Hu C, et al. Perivascular adipose tissue as an indication, contributor to, and therapeutic target for atherosclerosis[J\/OL]. Front Physiol. 2020;11:615503. https:\/\/doi.org\/10.3389\/fphys.2020.615503.","journal-title":"Front Physiol"},{"issue":"19","key":"4445_CR28","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","volume":"186","author":"J Massagu\u00e9","year":"2023","unstructured":"Massagu\u00e9 J, Sheppard D. TGF-\u03b2 signaling in health and disease[J\/OL]. Cell. 2023;186(19):4007\u201337. https:\/\/doi.org\/10.1016\/j.cell.2023.07.036.","journal-title":"Cell"},{"issue":"7","key":"4445_CR29","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1038\/s41401-024-01235-6","volume":"45","author":"ZJ Chia","year":"2024","unstructured":"Chia ZJ, Cao Y, nan LITTLEPJ, et al. Transforming growth factor-\u03b2 receptors: versatile mechanisms of ligand activation[J\/OL]. Acta Pharmacol Sin. 2024;45(7):1337\u201348. https:\/\/doi.org\/10.1038\/s41401-024-01235-6.","journal-title":"Acta Pharmacol Sin"},{"issue":"11","key":"4445_CR30","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1161\/ATVBAHA.120.312470","volume":"40","author":"HW Kim","year":"2020","unstructured":"Kim HW, Shi H, Winkler MA, Arteriosclerosis, et al. Thromb Vascular Biology. 2020;40(11):2569\u201376. https:\/\/doi.org\/10.1161\/ATVBAHA.120.312470.","journal-title":"Thromb Vascular Biology"},{"key":"4445_CR31","doi-asserted-by":"publisher","first-page":"107459","DOI":"10.1016\/j.carpath.2022.107459","volume":"61","author":"C Hillock-watling","year":"2022","unstructured":"Hillock-watling C, GOTLIEB A I. The pathobiology of perivascular adipose tissue (PVAT), the fourth layer of the blood vessel wall[J\/OL]. Cardiovasc Pathol. 2022;61:107459. https:\/\/doi.org\/10.1016\/j.carpath.2022.107459.","journal-title":"Cardiovasc Pathol"},{"issue":"4","key":"4445_CR32","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s12265-024-10502-0","volume":"17","author":"B Tesfamariam","year":"2024","unstructured":"Tesfamariam B. Impact of perivascular adipose tissue on neointimal formation following endovascular placement[J\/OL]. J Cardiovasc Transl Res. 2024;17(4):851\u20138. https:\/\/doi.org\/10.1007\/s12265-024-10502-0.","journal-title":"J Cardiovasc Transl Res"},{"issue":"38","key":"4445_CR33","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1093\/eurheartj\/ehad484","volume":"44","author":"C Antoniades","year":"2023","unstructured":"Antoniades C, Tousoulis D, Vavlukis M, et al. Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers[J\/OL]. Eur Heart J. 2023;44(38):3827\u201344. https:\/\/doi.org\/10.1093\/eurheartj\/ehad484.","journal-title":"Eur Heart J"},{"key":"4445_CR34","doi-asserted-by":"publisher","first-page":"110289","DOI":"10.1016\/j.cbi.2022.110289","volume":"369","author":"LL Ren","year":"2023","unstructured":"Ren LL, Li XJ, Duan TT, et al. Transforming growth factor-\u03b2 signaling: from tissue fibrosis to therapeutic opportunities[J\/OL]. Chemico-Biol Interact. 2023;369:110289. https:\/\/doi.org\/10.1016\/j.cbi.2022.110289.","journal-title":"Chemico-Biol Interact"},{"key":"4445_CR35","doi-asserted-by":"publisher","first-page":"1499340","DOI":"10.3389\/fphys.2024.1499340","volume":"15","author":"E Guo","year":"2024","unstructured":"Guo E, Liu D, Zhu Z. Phenotypic and functional disparities in perivascular adipose tissue[J\/OL]. Front Physiol. 2024;15:1499340. https:\/\/doi.org\/10.3389\/fphys.2024.1499340.","journal-title":"Front Physiol"},{"key":"4445_CR36","doi-asserted-by":"publisher","first-page":"1649179","DOI":"10.3389\/fonc.2025.1649179","volume":"15","author":"F Chen","year":"2025","unstructured":"Chen F, Lyu L, Xing C, et al. The pivotal role of TGF-\u03b2\/smad pathway in fibrosis pathogenesis and treatment[J\/OL]. Front Oncol. 2025;15:1649179. https:\/\/doi.org\/10.3389\/fonc.2025.1649179.","journal-title":"Front Oncol"},{"issue":"2","key":"4445_CR37","doi-asserted-by":"publisher","first-page":"oead010","DOI":"10.1093\/ehjopen\/oead010","volume":"3","author":"Z Li","year":"2023","unstructured":"Li Z, Belozertseva E, Parlakian A, et al. Smooth muscle \u03b1v integrins regulate vascular fibrosis via CD109 downregulation of TGF-\u03b2 signalling[J\/OL]. Eur Heart J Open. 2023;3(2):oead010. https:\/\/doi.org\/10.1093\/ehjopen\/oead010.","journal-title":"Eur Heart J Open"},{"issue":"18","key":"4445_CR38","doi-asserted-by":"publisher","first-page":"e37727","DOI":"10.1016\/j.heliyon.2024.e37727","volume":"10","author":"Y Yu","year":"2024","unstructured":"Yu Y, Cai Y, Yang F, et al. Vascular smooth muscle cell phenotypic switching in atherosclerosis[J\/OL]. Heliyon. 2024;10(18):e37727. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37727.","journal-title":"Heliyon"},{"key":"4445_CR39","doi-asserted-by":"publisher","unstructured":"Zhang C, Li Y, Chakraborty A et al. Aortic stress activates an adaptive program in thoracic aortic smooth muscle cells that maintains aortic strength and protects against aneurysm and dissection in mice[J\/OL]. Arteriosclerosis, Thrombosis, and Vascular Biology, 2023, 43(2): 234\u2013252. https:\/\/doi.org\/10.1161\/ATVBAHA.122.318135","DOI":"10.1161\/ATVBAHA.122.318135"},{"issue":"6","key":"4445_CR40","doi-asserted-by":"publisher","first-page":"e182629","DOI":"10.1172\/jci.insight.182629","volume":"10","author":"B Jiang","year":"2025","unstructured":"Jiang B, Ren P, He C, et al. Short-term disruption of TGF-\u03b2 signaling in adult mice renders the aorta vulnerable to hypertension-induced dissection[J\/OL]. JCI Insight. 2025;10(6):e182629. https:\/\/doi.org\/10.1172\/jci.insight.182629.","journal-title":"JCI Insight"},{"issue":"1","key":"4445_CR41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40246-023-00531-2","volume":"17","author":"EJ Rozen","year":"2023","unstructured":"Rozen EJ, Ozeroff CD, Allen MA. RUN(X) out of blood: emerging RUNX1 functions beyond hematopoiesis and links to down syndrome[J\/OL]. Hum Genomics. 2023;17(1):83. https:\/\/doi.org\/10.1186\/s40246-023-00531-2.","journal-title":"Hum Genomics"},{"issue":"8","key":"4445_CR42","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/cvr\/cvaa034","volume":"116","author":"A Riddell","year":"2020","unstructured":"Riddell A, Mcbride M, Braun T, et al. RUNX1: an emerging therapeutic target for cardiovascular disease[J\/OL]. Cardiovascular Res. 2020;116(8):1410\u201323. https:\/\/doi.org\/10.1093\/cvr\/cvaa034.","journal-title":"Cardiovascular Res"},{"issue":"16","key":"4445_CR43","doi-asserted-by":"publisher","first-page":"e183527","DOI":"10.1172\/JCI183527","volume":"134","author":"M XIng","year":"2024","unstructured":"XIng M, Chen W, Ji Y, et al. SLC44A2-mediated phenotypic switch of vascular smooth muscle cells contributes to aortic aneurysm[J\/OL]. J Clin Investig. 2024;134(16):e183527. https:\/\/doi.org\/10.1172\/JCI183527.","journal-title":"J Clin Investig"},{"issue":"1","key":"4445_CR44","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12964-023-01120-5","volume":"21","author":"G Cao","year":"2023","unstructured":"Cao G, Xuan X, Li Y, et al. Single-cell RNA sequencing reveals the vascular smooth muscle cell phenotypic landscape in aortic aneurysm[J\/OL]. Cell Communication Signal. 2023;21(1):113. https:\/\/doi.org\/10.1186\/s12964-023-01120-5.","journal-title":"Cell Communication Signal"},{"issue":"12","key":"4445_CR45","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.3390\/biomedicines13122999","volume":"13","author":"K Chen","year":"2025","unstructured":"Chen K, Wang S. The dual role of RUNX1 in inflammation-driven age-related diseases: from molecular mechanisms to clinical translation[J\/OL]. Biomedicines. 2025;13(12):2999. https:\/\/doi.org\/10.3390\/biomedicines13122999.","journal-title":"Biomedicines"},{"issue":"1","key":"4445_CR46","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1186\/s12872-025-05222-5","volume":"25","author":"J An","year":"2025","unstructured":"An J, Zhou W, Xia L, et al. Runx1 drives cardiac fibrosis and heart failure through epigenetic activation of myofibroblasts in pressure overload-induced cardiac remodeling[J\/OL]. BMC Cardiovasc Disord. 2025;25(1):746. https:\/\/doi.org\/10.1186\/s12872-025-05222-5.","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"4445_CR47","doi-asserted-by":"publisher","first-page":"e20190103","DOI":"10.1084\/jem.20190103","volume":"217","author":"NG Frangogiannis","year":"2020","unstructured":"Frangogiannis NG. Transforming growth factor\u2013\u03b2 in tissue fibrosis[J\/OL]. J Exp Med. 2020;217(3):e20190103. https:\/\/doi.org\/10.1084\/jem.20190103.","journal-title":"J Exp Med"},{"issue":"3","key":"4445_CR48","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jhip.2023.11.007","volume":"4","author":"S Li","year":"2023","unstructured":"Li S, Liu C. The critical role of signal transducers and activators of transcription-3 in the proliferation of vascular smooth muscle cells[J\/OL]. J Holist Integr Pharm. 2023;4(3):241\u20137. https:\/\/doi.org\/10.1016\/j.jhip.2023.11.007.","journal-title":"J Holist Integr Pharm"},{"key":"4445_CR49","doi-asserted-by":"publisher","unstructured":"Li B, Zhao Z, Xia Y et al. Mechanical stress accelerates vascular calcification by Piezo1\/BMP2 of vascular smooth muscle cells[J\/OL]. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2026, 1872(1): 168061. https:\/\/doi.org\/10.1016\/j.bbadis.2025.168061","DOI":"10.1016\/j.bbadis.2025.168061"},{"issue":"10","key":"4445_CR50","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s00424-024-03001-3","volume":"476","author":"L Catacuzzeno","year":"2024","unstructured":"Catacuzzeno L, Michelucci A. Emerging connections between Piezo1 and BK channels in vascular smooth muscle cells[J\/OL]. Pfl\u00fcgers Archiv -. Eur J Physiol. 2024;476(10):1475\u20137. https:\/\/doi.org\/10.1007\/s00424-024-03001-3.","journal-title":"Eur J Physiol"},{"issue":"1","key":"4445_CR51","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1186\/s12967-024-05411-4","volume":"22","author":"AO Giarratana","year":"2024","unstructured":"Giarratana AO, Prendergast CM, Salvatore MM, et al. TGF-\u03b2 signaling: critical nexus of fibrogenesis and cancer[J\/OL]. J Translational Med. 2024;22(1):594. https:\/\/doi.org\/10.1186\/s12967-024-05411-4.","journal-title":"J Translational Med"},{"key":"4445_CR52","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.2147\/JIR.S458948","volume":"17","author":"G Fan","year":"2024","unstructured":"Fan G, Lu J, Zha J, et al. TAK1 in vascular signaling: friend or foe?[J\/OL]. J Inflamm Res. 2024;17:3031\u201341. https:\/\/doi.org\/10.2147\/JIR.S458948.","journal-title":"J Inflamm Res"},{"key":"4445_CR53","doi-asserted-by":"publisher","first-page":"608976","DOI":"10.3389\/fimmu.2020.608976","volume":"11","author":"YR Xu","year":"2021","unstructured":"Xu YR, Lei CQ. TAK1-TABs complex: a central signalosome in inflammatory responses[J\/OL]. Front Immunol. 2021;11:608976. https:\/\/doi.org\/10.3389\/fimmu.2020.608976.","journal-title":"Front Immunol"},{"issue":"20","key":"4445_CR54","doi-asserted-by":"publisher","first-page":"10205","DOI":"10.3390\/ijms262010205","volume":"26","author":"N Lopacinska","year":"2025","unstructured":"Lopacinska N, Wesoly J, Bluyssen HAR. Interplay between KLF4, STAT, IRF, and NF-\u03baB in VSMC and macrophage plasticity during vascular inflammation and atherosclerosis[J\/OL]. Int J Mol Sci. 2025;26(20):10205. https:\/\/doi.org\/10.3390\/ijms262010205.","journal-title":"Int J Mol Sci"},{"key":"4445_CR55","doi-asserted-by":"publisher","first-page":"1400780","DOI":"10.3389\/fcvm.2024.1400780","volume":"11","author":"Y Xin","year":"2024","unstructured":"Xin Y, Zhang Z, Lv S, et al. Elucidating VSMC phenotypic transition mechanisms to bridge insights into cardiovascular disease implications[J\/OL]. Front Cardiovasc Med. 2024;11:1400780. https:\/\/doi.org\/10.3389\/fcvm.2024.1400780.","journal-title":"Front Cardiovasc Med"},{"key":"4445_CR56","doi-asserted-by":"publisher","first-page":"1417502","DOI":"10.3389\/fcell.2024.1417502","volume":"12","author":"X Sun","year":"2024","unstructured":"Sun X, Cao S, Mao C, et al. Post-translational modifications of p65: state of the art[J\/OL]. Front Cell Dev Biology. 2024;12:1417502. https:\/\/doi.org\/10.3389\/fcell.2024.1417502.","journal-title":"Front Cell Dev Biology"},{"key":"4445_CR57","doi-asserted-by":"publisher","first-page":"104570","DOI":"10.1016\/j.mvr.2023.104570","volume":"149","author":"DS Ko","year":"2023","unstructured":"Ko DS, Baek SE, Ha M, et al. Osteopontin is a key regulator of vascular smooth muscle cell proliferation in the outflow vein of arteriovenous fistulas[J\/OL]. Microvasc Res. 2023;149:104570. https:\/\/doi.org\/10.1016\/j.mvr.2023.104570.","journal-title":"Microvasc Res"},{"issue":"8","key":"4445_CR58","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s11883-024-01220-8","volume":"26","author":"X Guan","year":"2024","unstructured":"Guan X, Hu Y, Hao J, et al. Stress, vascular smooth muscle cell phenotype and atherosclerosis: novel insight into smooth muscle cell phenotypic transition in atherosclerosis[J\/OL]. Curr Atheroscler Rep. 2024;26(8):411\u201325. https:\/\/doi.org\/10.1007\/s11883-024-01220-8.","journal-title":"Curr Atheroscler Rep"},{"issue":"8","key":"4445_CR59","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s44161-023-00311-0","volume":"2","author":"D Wang","year":"2023","unstructured":"Wang D, Brady T, Santhanam L, et al. The extracellular matrix mechanics in the vasculature[J\/OL]. Nat Cardiovasc Res. 2023;2(8):718\u201332. https:\/\/doi.org\/10.1038\/s44161-023-00311-0.","journal-title":"Nat Cardiovasc Res"},{"issue":"1","key":"4445_CR60","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3390\/biomedicines14010201","volume":"14","author":"L Yin","year":"2026","unstructured":"Yin L, Wang X, Xiong N, et al. The role of the NF-\u03baB signaling pathway in atherosclerotic plaque rupture and targeted therapeutic strategies[J\/OL]. Biomedicines. 2026;14(1):201. https:\/\/doi.org\/10.3390\/biomedicines14010201.","journal-title":"Biomedicines"},{"issue":"42","key":"4445_CR61","doi-asserted-by":"publisher","first-page":"22011","DOI":"10.1074\/jbc.M116.715953","volume":"291","author":"MC Luo","year":"2016","unstructured":"Luo MC, Zhou SY, Feng DY, et al. Runt-related transcription factor 1 (RUNX1) binds to p50 in macrophages and enhances TLR4-triggered inflammation and septic shock[J\/OL]. J Biol Chem. 2016;291(42):22011\u201320. https:\/\/doi.org\/10.1074\/jbc.M116.715953.","journal-title":"J Biol Chem"},{"issue":"17","key":"4445_CR62","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3390\/cells14171365","volume":"14","author":"S Gupta","year":"2025","unstructured":"Gupta S, Hernandez G, Raman P. Cellular and molecular mechanisms of VSMC phenotypic switching in type 2 diabetes[J\/OL]. Cells. 2025;14(17):1365. https:\/\/doi.org\/10.3390\/cells14171365.","journal-title":"Cells"},{"issue":"16","key":"4445_CR63","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1093\/cvr\/cvac001","volume":"118","author":"EM Jeong","year":"2022","unstructured":"Jeong EM, Pereira M, So EY, et al. Targeting RUNX1 as a novel treatment modality for pulmonary arterial hypertension[J\/OL]. Cardiovascular Res. 2022;118(16):3211\u201324. https:\/\/doi.org\/10.1093\/cvr\/cvac001.","journal-title":"Cardiovascular Res"},{"key":"4445_CR64","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jvssci.2021.04.001","volume":"2","author":"R Chakraborty","year":"2021","unstructured":"Chakraborty R, Chatterjee P, Dave JM, et al. Targeting smooth muscle cell phenotypic switching in vascular disease[J\/OL]. JVS-Vascular Sci. 2021;2:79\u201394. https:\/\/doi.org\/10.1016\/j.jvssci.2021.04.001.","journal-title":"JVS-Vascular Sci"},{"issue":"5","key":"4445_CR65","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10616-023-00589-9","volume":"75","author":"D Dai","year":"2023","unstructured":"Dai D, Xie J, Zheng Y, et al. H3K27 acetylation-induced FSTL1 upregulation by P300\/RUNX1 co-activation exacerbated autophagy-mediated neuronal damage and NF-\u03baB-stimulated inflammation in alzheimer\u2019s disease[J\/OL]. Cytotechnology. 2023;75(5):449\u201360. https:\/\/doi.org\/10.1007\/s10616-023-00589-9.","journal-title":"Cytotechnology"},{"issue":"1","key":"4445_CR66","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13045-021-01053-x","volume":"14","author":"BG Kim","year":"2021","unstructured":"Kim BG, Malek E, Choi SH, et al. Novel therapies emerging in oncology to target the TGF-\u03b2 pathway[J\/OL]. J Hematol Oncol. 2021;14(1):55. https:\/\/doi.org\/10.1186\/s13045-021-01053-x.","journal-title":"J Hematol Oncol"},{"key":"4445_CR67","doi-asserted-by":"publisher","first-page":"157048","DOI":"10.1016\/j.cyto.2025.157048","volume":"196","author":"X Gao","year":"2025","unstructured":"Gao X, Li X, Zhang C, et al. Inhibiting TGF-\u03b2 signaling pathway for disease therapy: challenges and opportunities[J\/OL]. Cytokine. 2025;196:157048. https:\/\/doi.org\/10.1016\/j.cyto.2025.157048.","journal-title":"Cytokine"},{"key":"4445_CR68","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cytogfr.2025.08.003","volume":"86","author":"S Bhardwaj","year":"2025","unstructured":"Bhardwaj S, Gautam RK, Kushwaha S. From senescence to scarring: exploring TGF-\u03b2 signaling in cellular aging, fibrotic remodeling, and pulmonary fibrosis[J\/OL]. Cytokine Growth Factor Rev. 2025;86:29\u201339. https:\/\/doi.org\/10.1016\/j.cytogfr.2025.08.003.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"4445_CR69","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, et al. NF-\u03baB in biology and targeted therapy: new insights and translational implications[J\/OL]. Signal Transduct Target Therapy. 2024;9(1):53. https:\/\/doi.org\/10.1038\/s41392-024-01757-9.","journal-title":"Signal Transduct Target Therapy"},{"key":"4445_CR70","doi-asserted-by":"publisher","first-page":"101042","DOI":"10.1016\/j.drup.2023.101042","volume":"73","author":"Y Li","year":"2024","unstructured":"Li Y, Zhao B, Peng J, et al. Inhibition of NF-\u03baB signaling unveils novel strategies to overcome drug resistance in cancers[J\/OL]. Drug Resist Updates. 2024;73:101042. https:\/\/doi.org\/10.1016\/j.drup.2023.101042.","journal-title":"Drug Resist Updates"},{"issue":"7","key":"4445_CR71","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.3390\/cells9071627","volume":"9","author":"B Sehnert","year":"2020","unstructured":"Sehnert B, Burkhardt H, D\u00fcbel S, et al. Cell-type targeted NF-kappaB inhibition for the treatment of inflammatory diseases[J\/OL]. Cells. 2020;9(7):1627. https:\/\/doi.org\/10.3390\/cells9071627.","journal-title":"Cells"},{"issue":"1","key":"4445_CR72","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s00018-023-05098-8","volume":"81","author":"N Ebrahimi","year":"2024","unstructured":"Ebrahimi N, Abdulwahid AHRR, Mansouri A, et al. Targeting the NF-\u03baB pathway as a potential regulator of immune checkpoints in cancer immunotherapy[J\/OL]. Cell Mol Life Sci. 2024;81(1):106. https:\/\/doi.org\/10.1007\/s00018-023-05098-8.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"4445_CR73","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s44466-025-00014-0","volume":"1","author":"A Hoffmann","year":"2025","unstructured":"Hoffmann A, Cheng G, Baltimore D. NF-\u03baB: master regulator of cellular responses in health and disease[J\/OL]. Immun Inflamm. 2025;1(1):2. https:\/\/doi.org\/10.1007\/s44466-025-00014-0.","journal-title":"Immun Inflamm"},{"issue":"16","key":"4445_CR74","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1093\/cvr\/cvad107","volume":"119","author":"TP Martin","year":"2023","unstructured":"Martin TP, Macdonald EA, Bradley A, et al. Ribonucleicacid interference or small molecule inhibition of Runx 1 in the border zone prevents cardiac contractile dysfunction following myocardial infarction[J\/OL]. Cardiovascular Res. 2023;119(16):2663\u201371. https:\/\/doi.org\/10.1093\/cvr\/cvad107.","journal-title":"Cardiovascular Res"},{"issue":"1","key":"4445_CR75","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41392-024-02036-3","volume":"9","author":"H Nada","year":"2024","unstructured":"Nada H, Choi Y, Kim S, et al. New insights into protein\u2013protein interaction modulators in drug discovery and therapeutic advance[J\/OL]. Signal Transduct Target Therapy. 2024;9(1):341. https:\/\/doi.org\/10.1038\/s41392-024-02036-3.","journal-title":"Signal Transduct Target Therapy"},{"issue":"17","key":"4445_CR76","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.1039\/D1SC00165E","volume":"12","author":"H Wang","year":"2021","unstructured":"Wang H, Dawber RS, Zhang P, et al. Peptide-based inhibitors of protein\u2013protein interactions: biophysical, structural and cellular consequences of introducing a constraint[J\/OL]. Chem Sci. 2021;12(17):5977\u201393. https:\/\/doi.org\/10.1039\/D1SC00165E.","journal-title":"Chem Sci"},{"issue":"1","key":"4445_CR77","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00011-025-02021-8","volume":"74","author":"M Mahjoubin-tehran","year":"2025","unstructured":"Mahjoubin-tehran M, Rezaei S, Butler AE, et al. Decoy oligonucleotides targeting NF-\u03baB: a promising therapeutic approach for inflammatory diseases[J\/OL]. Inflamm Res. 2025;74(1):47. https:\/\/doi.org\/10.1007\/s00011-025-02021-8.","journal-title":"Inflamm Res"},{"issue":"19","key":"4445_CR78","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.1111\/febs.17220","volume":"291","author":"N Javaid","year":"2024","unstructured":"Javaid N, Ahmad B, Patra MC, et al. Decoy peptides that inhibit TNF signaling by disrupting the TNF homotrimeric oligomer[J\/OL]. FEBS J. 2024;291(19):4372\u201391. https:\/\/doi.org\/10.1111\/febs.17220.","journal-title":"FEBS J"},{"issue":"13","key":"4445_CR79","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1093\/cvr\/cvad130","volume":"119","author":"JR Pickett","year":"2023","unstructured":"Pickett JR, Wu Y, Zacchi LF, et al. Targeting endothelial vascular cell adhesion molecule-1 in atherosclerosis: drug discovery and development of vascular cell adhesion molecule-1\u2013directed novel therapeutics[J\/OL]. Cardiovascular Res. 2023;119(13):2278\u201393. https:\/\/doi.org\/10.1093\/cvr\/cvad130.","journal-title":"Cardiovascular Res"},{"key":"4445_CR80","doi-asserted-by":"publisher","unstructured":"Zhang Y, Zheng B, yang, Zhang Q et al. fan,. Nanoparticles targeting OPN loaded with BY1 inhibits vascular restenosis by inducing FTH1-dependent ferroptosis in vascular smooth muscle cells[J\/OL]. Biomaterials, 2024, 309: 122613. https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122613","DOI":"10.1016\/j.biomaterials.2024.122613"},{"issue":"33","key":"4445_CR81","doi-asserted-by":"publisher","first-page":"28767","DOI":"10.1021\/acsomega.2c00575","volume":"7","author":"X Huang","year":"2022","unstructured":"Huang X, Zhang Y, Zhang W, et al. Osteopontin-targeted and PPAR\u03b4-agonist-loaded nanoparticles efficiently reduce atherosclerosis in apolipoprotein E\u2013\/\u2013 mice[J\/OL]. ACS Omega. 2022;7(33):28767\u201378. https:\/\/doi.org\/10.1021\/acsomega.2c00575.","journal-title":"ACS Omega"},{"key":"4445_CR82","doi-asserted-by":"publisher","first-page":"1416737","DOI":"10.3389\/fddev.2024.1416737","volume":"4","author":"K Karpinska","year":"2024","unstructured":"Karpinska K, Li L, Wang T. Dual conjugation of magnetic nanoparticles with antibodies and siRNA for cell-specific gene silencing in vascular cells[J\/OL]. Front Drug Delivery. 2024;4:1416737. https:\/\/doi.org\/10.3389\/fddev.2024.1416737.","journal-title":"Front Drug Delivery"},{"issue":"1","key":"4445_CR83","doi-asserted-by":"publisher","first-page":"110196","DOI":"10.1016\/j.celrep.2021.110196","volume":"38","author":"X Zhang","year":"2022","unstructured":"Zhang X, Jin H, Huang X, et al. Robust genome editing in adult vascular endothelium by nanoparticle delivery of CRISPR-Cas9 plasmid DNA[J\/OL]. Cell Rep. 2022;38(1):110196. https:\/\/doi.org\/10.1016\/j.celrep.2021.110196.","journal-title":"Cell Rep"},{"issue":"12","key":"4445_CR84","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3390\/bioengineering11121222","volume":"11","author":"A Naskar","year":"2024","unstructured":"Naskar A, Kilari S, Baranwal G, et al. Nanoparticle-based drug delivery for vascular applications[J\/OL]. Bioengineering. 2024;11(12):1222. https:\/\/doi.org\/10.3390\/bioengineering11121222.","journal-title":"Bioengineering"},{"issue":"2","key":"4445_CR85","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ymthe.2024.01.005","volume":"32","author":"M Moazzam","year":"2024","unstructured":"Moazzam M, Zhang M, Hussain A, et al. The landscape of nanoparticle-based siRNA delivery and therapeutic development[J\/OL]. Mol Ther. 2024;32(2):284\u2013312. https:\/\/doi.org\/10.1016\/j.ymthe.2024.01.005.","journal-title":"Mol Ther"},{"issue":"7","key":"4445_CR86","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.3390\/biomedicines13071720","volume":"13","author":"D Bartusik-aebisher","year":"2025","unstructured":"Bartusik-aebisher D, Podg\u00f3rski R, Serafin I, et al. Targeted and biomimetic nanoparticles for atherosclerosis therapy: a review of emerging strategies[J\/OL]. Biomedicines. 2025;13(7):1720. https:\/\/doi.org\/10.3390\/biomedicines13071720.","journal-title":"Biomedicines"},{"key":"4445_CR87","doi-asserted-by":"publisher","first-page":"888563","DOI":"10.3389\/fphar.2022.888563","volume":"13","author":"J Chen","year":"2022","unstructured":"Chen J, Chang R. Association of TGF-\u03b2 canonical signaling-related core genes with aortic aneurysms and aortic dissections[J\/OL]. Front Pharmacol. 2022;13:888563. https:\/\/doi.org\/10.3389\/fphar.2022.888563.","journal-title":"Front Pharmacol"},{"issue":"12","key":"4445_CR88","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1161\/CIRCULATIONAHA.123.063332","volume":"148","author":"A Chakraborty","year":"2023","unstructured":"Chakraborty A, Li Y, Zhang C, et al. Epigenetic induction of smooth muscle cell phenotypic alterations in aortic aneurysms and dissections[J\/OL]. Circulation. 2023;148(12):959\u201377. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.063332.","journal-title":"Circulation"},{"issue":"12","key":"4445_CR89","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1161\/ATVBAHA.123.319329","volume":"43","author":"D Mizrak","year":"2023","unstructured":"Mizrak D, Zhao Y, Feng H, et al. Single-molecule spatial transcriptomics of human thoracic aortic aneurysms uncovers calcification-related CARTPT -expressing smooth muscle cells[J\/OL]. Thromb Vascular Biology. 2023;43(12):2285\u201397. https:\/\/doi.org\/10.1161\/ATVBAHA.123.319329. Arteriosclerosis.","journal-title":"Thromb Vascular Biology"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-026-04445-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04445-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04445-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:38:29Z","timestamp":1788993509000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13019-026-04445-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4445"],"URL":"https:\/\/doi.org\/10.1186\/s13019-026-04445-7","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"20 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"685"}}